What is the differential diagnosis (Ddx) of myositis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 17, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Differential Diagnosis of Myositis

The differential diagnosis of myositis must systematically distinguish inflammatory myopathies from noninflammatory myopathies, drug-induced conditions, metabolic disorders, infectious causes, and neuromuscular diseases that present with proximal weakness and elevated muscle enzymes.

Noninflammatory Myopathies

Muscular Dystrophies

  • Late-onset muscular dystrophy and limb-girdle dystrophy (dysferlinopathies) can present in adult years with proximal weakness and elevated CK, mimicking inflammatory myositis 1
  • Muscle biopsy shows reduction or absence of dystrophin with degenerating/regenerating fibers and replacement with fat or connective tissue; mononuclear cell invasion may occur, leading to confusion with polymyositis 1
  • Genetic testing for the dystrophin gene should be performed when muscular dystrophy is suspected 1

Mitochondrial Myopathies

  • Present with proximal weakness and can have elevated muscle enzymes 1
  • Histopathology reveals subsarcolemmal and interfibrillar accumulation of mitochondria with "ragged red fibers" on Gomori trichrome stain and reduction/absence of cytochrome c oxidase 1

Adult-Onset Nemaline Myopathy

  • Associated with monoclonal gammopathy and presents with proximal weakness 1

Myotonic Dystrophy Type 2

  • Can present with proximal muscle weakness in adults 1

Drug-Induced Myopathies

Statin-Induced Myopathy

  • Statins are much more likely than antipsychotics to cause muscle symptoms and should be considered first in patients on these medications 2
  • Typically presents with myalgia and mild CK elevation that resolves with drug discontinuation 1

Immune Checkpoint Inhibitor-Associated Myositis

  • More common with PD-1/PD-L1 inhibitors than ipilimumab 1
  • Can present as reactivation of preexisting paraneoplastic polymyositis/dermatomyositis or de novo myositis 1
  • May have fulminant necrotizing course with rhabdomyolysis and can involve myocardium, requiring urgent treatment 1
  • CK is often markedly elevated 1

Corticosteroid-Induced Myopathy

  • Should be considered in patients on chronic corticosteroid therapy 1
  • Typically has normal CK levels, distinguishing it from inflammatory myositis 1

Endocrine and Metabolic Myopathies

Thyroid Disorders

  • Both hypothyroidism and hyperthyroidism can cause proximal weakness 1

Hyperparathyroidism

  • Can present with muscle weakness and should be excluded with calcium and PTH levels 1

Infectious Myopathies

Viral Myositis

  • Benign self-limiting viral myositis is common and should be considered, especially with acute onset 2
  • Usually resolves spontaneously within days to weeks 2

HIV-Associated Myopathy

  • Shows strong resemblance to polymyositis 3

HTLV-1-Associated Myopathy

  • Can present as inflammatory myopathy 3

Rheumatologic Mimics

Polymyalgia Rheumatica

  • Presents with severe myalgia in proximal upper and lower extremities with severe fatigue 1
  • Key distinguishing feature: patients have pain but NOT true weakness 1
  • CK levels are within normal limits, differentiating from myositis 1
  • RF and anti-CCP are negative, but inflammatory markers (ESR, CRP) are highly elevated 1
  • MRI and EMG show no evidence of myopathy or muscle inflammation 1

Fibromyalgia

  • Presents with diffuse pain and fatigue without true weakness 1
  • Normal CK and inflammatory markers 1

Other Neuromuscular Conditions

Degenerative Joint Disease/Osteoarthritis

  • Can cause pain mimicking myositis but without true proximal weakness 1

Soft Tissue Rheumatic Disorders

  • Rotator cuff tendinitis and other soft tissue conditions can mimic myositis symptoms 1

Crystal Arthropathies

  • Gout and pseudogout should be excluded 1

Septic Arthritis

  • Must be ruled out in acute presentations 1

Critical Diagnostic Approach

Laboratory Evaluation

  • Measure CK and repeat in 3-5 days; persistent and marked elevation (>10x normal) suggests necrotizing myopathy 2
  • Inflammatory markers (ESR, CRP) are usually very elevated in inflammatory myositis 1
  • Request specific myositis autoantibodies (anti-Jo-1, anti-Mi-2, anti-MDA5, anti-SRP) if elevated CK persists 2, 1

Imaging and Electrodiagnostic Studies

  • EMG confirms myopathic process with polyphasic motor unit action potentials of short duration and low amplitude, increased insertional activity with fibrillation potentials 1
  • MRI shows diffuse muscle edema in true myositis 2

Muscle Biopsy

  • Muscle biopsy is the gold standard for confirming inflammatory myositis and distinguishing it from noninflammatory myopathies 1
  • Choose a weak muscle demonstrated by EMG abnormalities; biopsy the same muscle on the opposite side 1

Common Pitfalls

  • Do not confuse pain with weakness—true myositis causes proximal weakness (difficulty rising from chair, climbing stairs, lifting arms), not just myalgia 1, 2
  • Normal CK essentially excludes active inflammatory myositis (except in some cases of dermatomyositis or polymyalgia rheumatica) 1
  • Avoid sampling error by selecting an appropriately weak muscle for biopsy guided by EMG findings 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Antipsychotic-Associated Muscle Disorders

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

The pathological diagnosis of specific inflammatory myopathies.

Brain pathology (Zurich, Switzerland), 1992

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.